Armata Pharmaceuticals, Inc. (ARMP) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Armata Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | -1.31x |
| P/B Ratio | -1.04x |
| P/S Ratio | 46.41x |
| Profitability | |
| Gross Margin | 68.8% |
| Operating Margin | -636.7% |
| Net Margin | -3544.0% |
| EBITDA Margin | -605.4% |
| Liquidity | |
| Current Ratio | 1.19x |
| Quick Ratio | 1.19x |
| Leverage | |
| Debt/Equity | -1.32x |
YoY = year-over-year change. Source: FMP..